Sergey Yagoda

A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension

René S. Kahn, Bernard L. Silverman, Lauren DiPetrillo et al. · Schizophrenia Research · 2021 · 41 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Long-term safety and durability of effect with a combination of olanzapine and samidorphan in patients with schizophrenia: results from a 1-year open-label extension study

Sergey Yagoda, Christine Graham, Adam Simmons et al. · CNS Spectrums · 2020 · 32 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +16

Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study

Christoph U. Correll, Evan A. Stein, Christine Graham et al. · Schizophrenia Bulletin · 2022 · 24 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate

Lei Sun, Sergey Yagoda, Baiyun Yao et al. · Clinical Drug Investigation · 2019 · 20 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +16

Efficacy and Safety of a 2-Month Formulation of Aripiprazole Lauroxil With 1-Day Initiation in Patients Hospitalized for Acute Schizophrenia Transitioned to Outpatient Care

Peter J. Weiden, Amy Claxton, Jelena Kunovac et al. · The Journal of Clinical Psychiatry · 2020 · 20 citations

Pharmacy, Pharmacology, Pharmacotherapy +17